Iopentol (Imagopaque®) in vascular procedures: A multi-centre monitoring trial assessing adverse events and diagnostic information - Results from 3,587 patients in Germany

European Radiology

Volumn 7, Issue SUPPL. 4, 1997, Pages

  Muth, C P ^a   Henseke, P ^b   Grynne, B H ^c  

^a CARL THIEM KLINIKUM   (Germany)

^b Nycomed Arzneimittel GmbH   (Germany)

^c NYCOMED IMAGING AS   (Norway)

Author keywords

Adverse events; Contrast medium; Iopentol; Tolerance

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; IODOBENZOIC ACID DERIVATIVE; IOPENTOL;

ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; ERYTHEMA; EVALUATION; FEMALE; GERMANY; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NAUSEA; PHLEBOGRAPHY; RADIOGRAPHY; RISK FACTOR; SAFETY; URTICARIA; VASCULAR DISEASE;

ANGIOGRAPHY, DIGITAL SUBTRACTION; CONTRAST MEDIA; ERYTHEMA; EVALUATION STUDIES; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NAUSEA; PHLEBOGRAPHY; RISK FACTORS; SAFETY; TOMOGRAPHY, X-RAY COMPUTED; TRIIODOBENZOIC ACIDS; URTICARIA; VASCULAR DISEASES;

EID: 1542696775     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00006873     Document Type: Article

References (15)

1. Andrew E, Sveen K, Lambrechts M, Lillevold PE (1990) Total iopentol profile - overall results from clinical trials. In: Lærum F, Kendall B (eds) Iopentol. Clinical trials with a new non-ionic contrast medium. Excerpta Medica Int Congr Series 909. Elsevier, Amsterdam New York Oxford, pp 189-197
2. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K (1990) Adverse reactions to ionic and non-ionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175: 621-628
3. Heywood R, Mayfield R, Allan JA, Michelet ÅA (1987) Summary of the toxicologic profile of iopentol. In: Boijsen E, Kormano M (eds) Iopentol. Chemistry, toxicology and pharmacology of a non-ionic contrast medium. Acta Radiol [Suppl] 370: 45-49
4. Waaler A, Jørgensen NP, Koksvik B, Skinnemoen K, Andrew E (1987) Pharmacokinetics of iopentol in healthy volunteers. In: Bojsen E, Kormano M (eds) Iopentol. Chemistry, toxicology and pharmacology of a non-ionic contrast medium. Acta Radiol [Suppl] 370: 113-117
5. Schrott KM, Behrends B, Clauss W, Kaufmann J, Lehnert J (1986) Iohexol in excretory urography. Results of the drug monitoring programme. Fortschr Med 104: 153-156
6. Skalpe IO, Nakstad P (1989) Myelography with iohexol (Omnipaque®) - a clinical report with special reference to the adverse effects. Neuroradiology 30: 169-174
7. Levorstad K, Vatne K, Brodahl U, Laake B, Simonsen S, Aakhus T (1989) Safety of non-ionic contrast medium Omnipaque® in coronary angiography. Cardiovasc Intervent Radiol 12: 98-100
8. Hill JA, Winniford M, Cohen MB et al. (1993) Multicenter trial of ionic versus non-ionic contrast media for cardiac angiography. Am J Cardiol 72: 770-775
9. Jakobsen JÅ, Hagve TA, Holager Tet al. (1989) Safety and tolerability of the non-ionic contrast medium iopentol. An intravenous phase I trial. Eur J Radiol 9: 203-207
10. Halpern EF (1994) Inadequacy of sample sizes in clinical trials of laboratory parameters attributable to invalid statistical assumptions. Clin Pharmacol Ther 56: 434-444
11. Matthai WH JR, Kussmaul WG III, Krol J, Goin JE Schwartz JS, Hirshfeld JW JR (1994) A comparison of low- with high-osmolality contrast agents in cardiac angiography: identification of criteria for selective use. Circulation 89: 291-301
12. Katayama H, Kozuka T, Ebata K (1994) Assessment of the side-effects of iomeprol. Eur J Radiol [Suppl] 18:S115-S119
13. Rosati G, Davies A, Spinazzi A (1995) Predictable and unpredictable adverse reactions to iomeprol and iopromide. Contrast Media Research Naantali, Finland, June 17-22, p 14
14. Floriani I, Ciceri M, Torri V, Tinazzi A, Jahn H, Noseda A (1996) Clinical profile of ioversol - a metaanalysis of 57 randomized double-blind clinical-trials. Invest Radiol 31: 479-491
15. Powe NR, Moore RD, Steinberg EP (1993) Adverse reactions to contrast media - factors that determine the cost of treatment. Am J Roentgenol 161: 1089-1095